64578-0153 NDC - LYMPH-TONE II (AESCULUS HIPP, AZADIRACHTA, BARYTA CARB, BERBER VULG, BOLDO, BUFO, CALC CARB, CALC PHOS, COENZYME A, COLLINSONIA, ECHINACEA, FERRUM PHOS, GLANDULA SUPRARENALIS SUIS, HYPOTHALAMUS, KREOSOTUM, NADIDUM, NAT MUR, PHOS, PHYTOLACCA, PINUS SYL, PITUITARUM POSTERIUM, PIX LIQUIDA, PULSATILLA, SILICEA, STILLINGIA, THUJA OCC.)

Drug Information

Product NDC: 64578-0153

Proprietary Name: Lymph-Tone II

Non Proprietary Name: Aesculus hipp, Azadirachta, Baryta carb, Berber vulg, Boldo, Bufo, Calc carb, Calc phos, Coenzyme A, Collinsonia, Echinacea, Ferrum phos, Glandula suprarenalis suis, Hypothalamus, Kreosotum, Nadidum, Nat mur, Phos, Phytolacca, Pinus syl, Pituitarum posterium, Pix liquida, Pulsatilla, Silicea, Stillingia, Thuja occ.

Active Ingredient(s):
  • 8 [hp_X]/59.1mL AZADIRACHTA INDICA BARK;
  • 12 [hp_X]/59.1mL BARIUM CARBONATE;
  • 12 [hp_X]/59.1mL BERBERIS VULGARIS ROOT BARK;
  • 12 [hp_X]/59.1mL BOS TAURUS HYPOTHALAMUS;
  • 12 [hp_X]/59.1mL BOS TAURUS PITUITARY GLAND;
  • 12 [hp_X]/59.1mL BUFO BUFO CUTANEOUS GLAND;
  • 12 [hp_X]/59.1mL COENZYME A;
  • 10 [hp_X]/59.1mL COLLINSONIA CANADENSIS ROOT;
  • 6 [hp_X]/59.1mL ECHINACEA ANGUSTIFOLIA;
  • 12 [hp_X]/59.1mL FERRUM PHOSPHORICUM;
  • 12 [hp_X]/59.1mL HORSE CHESTNUT;
  • 12 [hp_X]/59.1mL NADIDE;
  • 12 [hp_X]/59.1mL OYSTER SHELL CALCIUM CARBONATE, CRUDE;
  • 4 [hp_X]/59.1mL PEUMUS BOLDUS LEAF;
  • 30 [hp_X]/59.1mL PHOSPHORUS;
  • 4 [hp_X]/59.1mL PHYTOLACCA AMERICANA ROOT;
  • 6 [hp_X]/59.1mL PINE TAR;
  • 9 [hp_X]/59.1mL PINUS SYLVESTRIS LEAFY TWIG;
  • 12 [hp_X]/59.1mL PULSATILLA VULGARIS;
  • 12 [hp_X]/59.1mL SILICON DIOXIDE;
  • 12 [hp_X]/59.1mL SODIUM CHLORIDE;
  • 4 [hp_X]/59.1mL STILLINGIA SYLVATICA ROOT;
  • 9 [hp_X]/59.1mL SUS SCROFA ADRENAL GLAND;
  • 12 [hp_X]/59.1mL THUJA OCCIDENTALIS LEAFY TWIG;
  • 12 [hp_X]/59.1mL TRIBASIC CALCIUM PHOSPHATE;
  • 15 [hp_X]/59.1mL WOOD CREOSOTE


Administration Route(s): ORAL

Dosage Form(s): LIQUID

Pharmacy Class(es):
  • Blood Coagulation Factor [EPC];
  • Calcium [CS];
  • Cations;
  • Divalent [CS];
  • Increased Coagulation Factor Activity [PE];
  • Phosphate Binder [EPC];
  • Phosphate Chelating Activity [MoA]

Labeler Information

Labeler Name: Energetix Corporation
Product Type: HUMAN OTC DRUG
FDA Application Number:
Marketing Category: UNAPPROVED HOMEOPATHIC
Start Marketing Date:11/3/2017

Package Information

No. Package Code Package Description Billing Unit
164578-0153-159.1 mL in 1 BOTTLE, DROPPER (64578-0153-1)

NDC Record

Field Name Field Value Definition
PRODUCT NDC64578-0153The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC.
PRODUCT TYPE NAMEHUMAN OTC DRUGIndicates the type of product, such as Human Prescription Drug or Human Over the Counter Drug. This data element matches the “Document Type” field of the Structured Product Listing.
PROPRIETARY NAMELymph-Tone IIThe proprietary name also known as the trade name is the name of the product chosen by the medication labeler for marketing purposes.
NON PROPRIETARY NAMEAesculus hipp, Azadirachta, Baryta carb, Berber vulg, Boldo, Bufo, Calc carb, Calc phos, Coenzyme A, Collinsonia, Echinacea, Ferrum phos, Glandula suprarenalis suis, Hypothalamus, Kreosotum, Nadidum, Nat mur, Phos, Phytolacca, Pinus syl, Pituitarum posterium, Pix liquida, Pulsatilla, Silicea, Stillingia, Thuja occ.The non-proprietary name is sometimes called the generic name. The generic name usually includes the active ingredient(s) of the product.
DOSAGE FORM NAMELIQUIDThe translation of the dosage form Code submitted by the firm.
ROUTE NAMEORALThe translation of the route code submitted by the firm, indicating route of administration.
START MARKETING DATE11/3/2017This is the date that the labeler indicates was the start of its marketing of the drug product.
MARKETING CATEGORY NAMEUNAPPROVED HOMEOPATHICProduct types are broken down into several potential Marketing Categories, such as NDA/ANDA/BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
LABELER NAMEEnergetix CorporationName of Company corresponding to the labeler code segment of the Product NDC.
SUBSTANCE NAMEAZADIRACHTA INDICA BARK; BARIUM CARBONATE; BERBERIS VULGARIS ROOT BARK; BOS TAURUS HYPOTHALAMUS; BOS TAURUS PITUITARY GLAND; BUFO BUFO CUTANEOUS GLAND; COENZYME A; COLLINSONIA CANADENSIS ROOT; ECHINACEA ANGUSTIFOLIA; FERRUM PHOSPHORICUM; HORSE CHESTNUT; NADIDE; OYSTER SHELL CALCIUM CARBONATE, CRUDE; PEUMUS BOLDUS LEAF; PHOSPHORUS; PHYTOLACCA AMERICANA ROOT; PINE TAR; PINUS SYLVESTRIS LEAFY TWIG; PULSATILLA VULGARIS; SILICON DIOXIDE; SODIUM CHLORIDE; STILLINGIA SYLVATICA ROOT; SUS SCROFA ADRENAL GLAND; THUJA OCCIDENTALIS LEAFY TWIG; TRIBASIC CALCIUM PHOSPHATE; WOOD CREOSOTEAn active ingredient is the substance responsible for the medicinal effects of a product specified by the substance's molecular structure or if the molecular structure is not known, defined by an unambiguous definition that identifies the substance. Each active ingredient name is the preferred term of the UNII code submitted.
ACTIVE NUMERATOR STRENGTH8; 12; 12; 12; 12; 12; 12; 10; 6; 12; 12; 12; 12; 4; 30; 4; 6; 9; 12; 12; 12; 4; 9; 12; 12; 15 
ACTIVE INGRED UNIT[hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL 
PHARM CLASSESBlood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA] 

Download Record

Download this NDC record in Text format: Export

Download this NDC record in Excel (CSV) format: Export

Download this NDC record in XML format: Export

This page was last updated on: 5/3/2024